Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-dfsvx Total loading time: 0 Render date: 2024-04-26T15:31:40.249Z Has data issue: false hasContentIssue false

Chapter 18 - The use of botulinum neurotoxin in tic disorders and essential hand and head tremor

Published online by Cambridge University Press:  05 February 2014

Joseph Jankovic
Affiliation:
Parkinson’s Disease Center and Movement Disorder Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX, USA
Daniel Truong
Affiliation:
The Parkinson’s and Movement Disorders Institute, Fountain Valley, California
Dirk Dressler
Affiliation:
Department of Neurology, Hannover University Medical School
Mark Hallett
Affiliation:
George Washington University School of Medicine and Health Sciences, Washington, DC
Christopher Zachary
Affiliation:
Department of Dermatology, University of California, Irvine
Get access

Summary

Introduction

This chapter describes aspects of tics and tremors including clinical features, oral medication treatment and the utility of botulinum neurotoxin (BoNT) injections as a therapeutic modality.

Tics

Tics are brief, sudden, movements (motor tics) or sounds (phonic tics) that are intermittent but may be repetitive and stereotypic (Jankovic and Kurlan, 2011). When motor tics and phonic tics coexist without other neurological abnormalities, the diagnosis of Tourette’s syndrome should be considered. Most patients with Tourette’s syndrome have also a variety of comorbid disorders such as attention deficit disorder, obsessive compulsive disorder and impulse control disorders. Tourette’s syndrome is considered a genetic neurodevelopmental disorder but its pathogenesis is not well understood (Jankovic and Kurlan, 2011). Although Tourette’s syndrome is the most common cause of childhood-onset tics, there are many other causes of tics, including autistic disorder and various insults to the brain and basal ganglia (infection, stroke, head trauma, drugs and neurodegenerative disorders).

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2014

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Brin, MF, Lyons, KE, Doucette, J et al. (2001). A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor. Neurology, 56, 1523–8.CrossRefGoogle ScholarPubMed
Cheung, MY, Shahed, J, Jankovic, J (2007). Malignant Tourette syndrome. Mov Disord, 22, 1743–50.CrossRefGoogle ScholarPubMed
Elble, R, Deuschl, G (2011). Milestones in tremor research. Mov Disord, 26, 1096–105.CrossRefGoogle ScholarPubMed
Jankovic, J (1994). Botulinum toxin in the treatment of dystonic tics. Mov Disord, 9, 347–9.CrossRefGoogle ScholarPubMed
Jankovic, J, Clarence-Smith, K (2011). Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders. Expert Rev Neurotherapeut, 11, 1509–23.CrossRefGoogle ScholarPubMed
Jankovic, J, Kurlan, R (2011). Tourette syndrome: Evolving concepts. Mov Disord, 26, 1149–56.CrossRefGoogle ScholarPubMed
Jankovic, J, Schwartz, K (1991). Botulinum toxin treatment of tremors. Neurology, 41, 1185–8.CrossRefGoogle ScholarPubMed
Jankovic, J, Schwartz, K, Clemence, W, Aswad, A, Mordaunt, JA (1996). Randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor. Mov Disord, 3, 250–6.CrossRefGoogle Scholar
Kendall, KA, Leonard, RJ (2011). Interarytenoid muscle botox injection for treatment of adductor spasmodic dysphonia with vocal tremor. J Voice 25, 114–19.CrossRefGoogle ScholarPubMed
Krauss, JK, Jankovic, J (1996). Severe motor tics causing cervical myelopathy in Tourette’s syndrome. Mov Disord, 11, 563–6.CrossRefGoogle ScholarPubMed
Kwak, C H, Hanna, PA, Jankovic, J (2000). Botulinum toxin in the treatment of tics. Arch Neurol, 57, 1190–3.CrossRefGoogle ScholarPubMed
Marras, C, Andrews, D, Sime, E, Lang, AE (2001). Botulinum toxin for simple motor tics: a randomized, double-blind, controlled clinical trial. Neurology, 56, 605–10.CrossRefGoogle ScholarPubMed
Pacchetti, C, Mancini, F, Bulgheroni, M et al. (2000). Botulinum toxin treatment for functional disability induced by essential tremor. Neurol Sci, 21, 349–53.CrossRefGoogle ScholarPubMed
Pahwa, R, Busenbark, K, Swanson-Hyland, EF et al. (1995). Botulinum toxin treatment of essential head tremor. Neurology, 45, 822–4.CrossRefGoogle ScholarPubMed
Porta, M, Maggioni, G, Ottaviani, F, Schindler, A (2004). Treatment of phonic tics in patients with Tourette’s syndrome using botulinum toxin type A. Neurol Sci, 24, 420–3.CrossRefGoogle ScholarPubMed
Pringsheim, T, Doja, A, Gorman, D et al. (2012). Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy. Can J Psychiatry, 57, 133–43.CrossRefGoogle ScholarPubMed
Scott, BL, Jankovic, J, Donovan, DT (1996). Botulinum toxin into vocal cord in the treatment of malignant coprolalia associated with Tourette’s syndrome. Mov Disord, 11, 431–3.CrossRefGoogle ScholarPubMed
Vincent, DA (2008). Botulinum toxin in the management of laryngeal tics. J Voice 22, 251–6.CrossRefGoogle ScholarPubMed
WE MOVE Spasticity Study Group (2005). BTX-A Adult Dosing Guidelines. New York: WE MOVE (, accessed 21 May 2013).Google Scholar
Zesiewicz, TA, Elble, RJ, Louis, ED et al. (2011). Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 77, 1752–5.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×